Significance of thrombinemia in patients with aortic valve stenosis
https://doi.org/10.18705/1607-419X-2009-15-5-575-579
Abstract
About the Authors
N. S. GoncharovaRussian Federation
O. M. Moiseeva
Russian Federation
G. M. Aleshina
Russian Federation
E. V. Shlyakhto
Russian Federation
References
1. Вавилова Т.В., Головина О.Г., Зайнулина М.С. и др. Гемостаз, Физиологические механизмы, принципы диагностики основных форм геморрагических заболеваний / Под ред. Н.Н. Петрищева, Л.П. Папаян. - СПб. : Изд-во СПБГМУ, 1999. - 121 с.: ил.
2. Goldsmith I.R., Blann A.D. Patel R.L., Lip G.Y. Plasma fibrinogen, soluble P-selectin, and von Willebrand factor in aortic valve disease: evidence for abnormal haemorheology, platelet activation, and endothelial dysfunction // Heart. - 2000. - Vol. 83. № 5. - P. 577-578.
3. Ghaisas N.K., Foley J.B., O'Briain D.S. et al. Adhesion molecules in nonrheumatic aortic valve disease: endothelial expression, serum levels and effects of valve replacement // J. Am. Coll. Cardiol. - 2000. - Vol. 36, № 7. - P. 2257-2262.
4. Шиффман Ф.Дж. Патофизиология кропи. Пер. с англ. // Под ред. Ю.В. Наточина. - СПб. : «Невский Диалект». 2000. - 448 с: ил.
5. Patterson С., Stouffer G., Madamanchi N., Runge M. New Tricks for old dogs: nonthrombotic effects of thrombin in vessel wall biology // Circ. Res. - 2001. - Vol. 88. № 10. - P. 987-997.
6. Major CD., Santulli R.J., Derian C.K., Andrade-Gordon P. Extraccl-lular mediators in atherosclerosis and thrombosis lessons from thrombin receptor knockout mice // Arterioscler. thromb. vasc. biol. - 2003. - Vol. 23, № 6. - P. 931-939.
7. Steinberg S.F. The cardiovascular actions of protease-activated receptors // Mol. Pharmacol. - 2005. - Vol. 67, № 1. - P. 2 11.
8. Пегрищев Н.Н. Дисфункция эндотелия. Причины, механизмы, фармакологическая коррекция. - СПб.: Изд-во СПбГМУ, 2003. - 184 с.
9. Esmon С., Fukudome К., Mather Т. et al. Inflammation, sepsis, and coagulation // Haematologica. - 1999. - Vol. 84, № 3. - P. 254-259.
10. Sabri A., Muske G., Zhang H. et al. Signaling properties and functions of two distinct cardiomyocyle protease-activated receptors // Circ. Res. - 2000. - Vol. 86, № 10. - P. 1054-1061.
11. Devereux R.B., Reichek N. Echocardiography - determination of left ventricular mass in man. Anatomic validation of the method // Circulation. - 1977. - Vol. 55, № 4. - P. 613-618.
12. Skowasch D., Sehrempf S., Preusse С. et al. Tissue resident С reactive protein in degenerative aortic valves: correlation with serum С reactive protein concentrations and modification by statins // Heart. - 2006. - Vol. 92, № 4. - P. 495-498.
13. Sensky P., Loubani M., Keal R. et al. Does the type of prosthesis influence early left ventricular mass regression after aortic valve replacement? Assessment with magnetic resonance imaging // Am. Heart.J. 2003. - Vol. 146, № 4. - P. 746.
14. Sharma U., Barenbrug P., Pokharel S. et al. Systematic review of the outcome of aortic valve replacement in patients with aortic stenosis // Arm. Thorac. Surg. - 2004. - Vol. 78. № 1. - P. 90-95.
15. Raza S.L., Nehring L.C., Shapiro S.D., Cornelius L.A. Protein-ase-activated receplor-1 regulation of macrophage elastase (MMP 12) secretion by serine proteinases // J. Biol. Chem. - 2000. Vol. 275, № 52. - P. 41243-41250.
16. Levi M., van der Poll Т., Bullcr 11.R. Bidirectional relation between inflammation and coagulation. Review: current perspective // Circulation. - 2004. - Vol. 109, № 22. - P. 2698-2704.
17. Gibbs C.R., Blann A.D. Robert D.S., Lip G.Y. Abnormalities of hemorheological. endothelial, and platelet function in patients with chronic heart failure in sinus rhythm. Effects of angiotensin-converting enzyme inhibitor and R-blocker therapy // Circulation. - 2001. - Vol. 103, № 13. - P. 1746-1751.
18. Celi A., Pellegrini G., Lorenzet R. et al. P-selectin induces the expression of tissue factor on monocytes // Proc. Natl. Acad. Sci. USA. 1994. - Vol. 91. № 19. - P. 8767-8771.
19. Szmitko P.E., Wang C.-H., Weisel R.D. et al. Biomarkers of vascular disease linking inflammation to endothelial activation. Part II // Circulation. - 2003. - Vol. 108, № 17. - P. 2041-2048.
20. Cleator J.H., Zhu W.Q., Vaughan D.E. et al. Differential regulation of endothelial exocytosis of P-selectin and von Willebrand factor by protease-activated receptors and cAMP // Blood. 2006. - Vol. 107, № 7. - P. 2736-2744.
21. Струкова С.М. Роль тромбоцитов и сериновых протеаз в сопряжении свертывающей системы крови и воспаления // Биохимия (Москва). - 2004. - Вып. 69. № 10. - С. 1067-1081.
22. Moshal К., Tyagi N., Henderson В., Ovechkin A. Protease-activated receptor and endothelial-myocyte uncoupling in chronic heart failure// Am. J. Physiol. Heart Circ. Physiol. - 2005. - Vol. 288. № 6. - P. 2770-2777.
23. Opie L.H. Cellular basis for therapeutic choices in heart failure // Circulation. - 2004. - Vol. 110, № 17. - P. 2559-2561.
24. Ossovskaya V.S., Bunnett N.W. Protease-activated receptors: Contribution to physiology and disease // Physiol. Rev. - 2004. - Vol. 84, № 2. - P. 579-621.
25. Sabri A., Short J., Guo J., Steinberg S.F. Protease-activated receptor-1-mediated DNA synthesis in cardiac fibroblast is via epidermal growth factor receptor transactivation: distinct PAR I signaling pathways in cardiac fibroblasts and cardiomyocytes // Circ. Res. - 2002. - Vol. 91. № 6. - P. 532-539.
26. Jiang Т., Kuznelsov V., Pak E. et al. Thrombin receptor actions in neonatal rat ventricular myocytes // Circ. Res. - 1996. - Vol. 78, № 4. - P. 553-563.
Review
For citations:
Goncharova N.S., Moiseeva O.M., Aleshina G.M., Shlyakhto E.V. Significance of thrombinemia in patients with aortic valve stenosis. "Arterial’naya Gipertenziya" ("Arterial Hypertension"). 2009;15(5):575-579. (In Russ.) https://doi.org/10.18705/1607-419X-2009-15-5-575-579